NeuroTx develops advanced AI-based technology for digital drug development and offers tailored digital therapeutics for managing neuropsychological disorders. Their solutions enable optimized treatment of mental health disorders.

Vision and Mission: NeuroTx’s vision is to pioneer in the digital therapeutics space, enhancing drug development and management of mental health through AI-powered systems. Their mission is to provide healthcare professionals with innovative tools for treating neuropsychological disorders effectively.

Noteworthy Points:

• Founded in 2015 and based in Seoul, South Korea.
• Raised a Later Stage VC funding of $1.69M in April 2023.
• Holds a patent for a neurostimulation-based neurofeedback device.